CBRC Media Coverage
Study reveals mechanism linking heart disease to cancer development
Researchers at Tel Aviv University (TAU) and the Leviev Cardiothoracic and Vascular Center at the Sheba Medical Center have found a mechanism responsible for increasing the risk of developing cancer among patients with heart disease: Small extracellular bubbles, or vesicles (sEVs), secreted from the sick heart to heal itself, are released into the bloodstream and promote the growth of cancer cells throughout the body. (medicalxpress.com, 9.4.2024)
Israeli researchers reach bone metastasis breakthrough for breast cancer patients
Groundbreaking study at Tel Aviv University: Existing drugs may hinder the development of bone metastasis in breast cancer patients (The Jerusalem Post, 3.4.2024)
RNA Therapy Drug Delivery System Targets Cancer Destruction
Researchers at Tel Aviv University destroyed 90% of the multiple myeloma blood cancer cells under laboratory conditions, and 60% in human tissues taken from patients at Rabin Medical Center (Belinson Hospital), using an RNA-based drug delivered to the cells by targeted lipid nanoparticles (miragenews.com, 30.7.2023)
Cancer Research Pioneer Who Paved the Tumor Microenvironment Field to Receive the 2023 Szent-Györgyi Prize for Progress in Cancer Research
The National Foundation for Cancer Research (NFCR) announced today that Isaac P. Witz, Ph.D., has been selected to receive the 2023 Szent-Györgyi Prize for Progress in Cancer Research. (businesswire.com, 31.5.2023)
Ph.D. Student Ron Kleiner of the Satchi-Fainaro's Lab was selected for prestigious Forbes 30 UNDER 30
Forbes 30 UNDER 30 - Ron Kleiner, a Ph.D. student in cancer research, is working on a scientific breakthrough that will change the face of the medical world - a vaccine for gastrointestinal cancers, including pancreatic cancer, which is the fourth leading cause of death among cancers (Forbes, 27.2.2023)
Forbes Israel 30Under30 2023 >>
Three common drugs may reduce risk of metastases after colon, rectal cancer
Readily available, side-effect-free medication can prevent metastases, anxiety and stress reactions after surgery (The Jerusalem Post, 7.12.2022)
Israeli scientists: Breast cancer relapse in mice down 88% by adding drug to chemo
Tel Aviv University researchers say anti-inflammatory medicine can prevent cancer cells from ‘hiding’ and growing in tissue inflamed by the original treatment (The Times of Israe, 8.11.2022)
New treatment could increase efficacy of chemo, prevent metastasis - TAU study
The number of women who recover from this malignancy is steadily on the rise, thanks to early detection, enhanced treatment techniques and heightened awareness (The Jerusalem Post, 8.11.2022)
New technology enables discovery of drugs that reduce melanoma brain metastasis
Innovative research succeeded in delaying the spread of skin cancer using 3D models • Following the use of the printed model, the researchers discovered that an existing drug prevents the spread of the disease (N12, 20.9.2022)
Brain tumors vanish in mice after Israeli study finds and destroys "power source"
Work starting on human drug after researchers discover specific brain cells are giving glioblastoma tumors energy and, when removed, tumors wither (The Times of Israel, September 1, 2022)
Brain cancer in mice eradicated in groundbreaking Israeli study
A groundbreaking cancer study at Tel Aviv University found a way to eradicate a deadly type of brain cancer in mice (The Jerusalem Post, September 1, 2022)
Israeli researchers closer to curing incurable cancer
Dr. Lior Mayo joins host David Matlin to discuss the research being done at Tel Aviv University to cure an incurable cancer (i24NEWS, Sep 1, 2022)
Portrait: Professor Satchi-Fainaro, one of Israel’s most renowned scientists
Ranked 24th out of 50 on Forbes business magazine's list of Israel's most influential women last month, researcher Ronit Satchi-Fainaro is one of the country's most renowned scientists, thanks to her achievements in cancer research (i24 NEWS August 09, 2022)
CRISPR gene editing may cause permanent damage - study
Caution from researchers at Tel Aviv University: CRISPR gene editing can damage the genome and might trigger cancer (The Jerusalem Post, July 24, 2022)
Exposure to the sun makes men hungrier than women - Israeli study
Tel Aviv University Research: Open your wallets! Men will be much hungrier than women when they expose themselves to the sun’s rays (The Jerusalem Post, July 19, 2022)
Prof. Shai Izraeli received two prestigious international awards
Director of the Hemato-Oncology Division at Schneider Children's won the ICRF prize and the EHA prize (June 29, 2022)
Israeli 2-in-1 cancer drug shows promise in boosting chemo and immunotherapy
Encouraging results seen in mice study for world’s first RNA-based drug of its kind; it helps chemotherapy attack tumors and assists immunotherapy in strengthening immune system (The Times of Israel, April 5, 2022)
Israeli researchers find 'double-agent' cells that fight brain cancer - study
The findings of the study showed that there are immune system cells that, despite the fact that their primary function is to attack and kill the cancer cells, actually act as "double agents" (The Jerusalem Post, 6.10.2021)
